Evidence map›Paper›PMID 41535595›Full record

ArticleCommunications chemistry2026

Molecular driving force of a small molecule-induced protein disorder-order transition.

Cesar Mendoza-Martinez, Arun A Gupta, Salomé Llabrés, Paul N Barlow, Julien Michel

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cesar Mendoza-Martinez *EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3439-9809
Arun A Gupta *EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.
Salomé Llabrés *EaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2039-7821
Paul N BarlowEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK.
Julien MichelEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh, UK. julien.michel@ed.ac.uk.ORCID http://orcid.org/0000-0003-0360-1760

Funding

EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)) 336289RCUK | Engineering and Physical Sciences Research Council (EPSRC) EL/L000253/1 and EP/W030276/1Wellcome TrustWellcome Trust (Wellcome) 101527/Z13/Z
6 · The paper itself

Abstract

The selectivity and affinity of numerous protein-protein interactions depends upon the folding of intrinsically disordered regions (IDRs) that accompanies complexation. Here we investigate how folding-on-binding of a protein IDR by small molecules is facilitated by synergestic exploitation of interactions with a folded protein region. To this end, the molecular driving forces that underpin ordering of the N-terminal intrinsically disordered 'lid' region of the oncoprotein MDM2 by the small molecule AM-7209 were elucidated by a combination of molecular dynamics simulations, calorimetry and NMR measurements. Strikingly, mutations of lid residues distant from the ligand-binding site modulate potency by up to three orders of magnitude. A key requirement for conversion of this IDR into an ordered motif is collective stabilisation of a network of non-polar contacts between a chlorophenyl moiety of AM-7209 and the lid residue I19 to overcome conformational entropy loss associated with folding of the IDR. Our findings underscore the crucial role that protein IDRs can play in drug-resistance mechanisms and expand strategies available to medicinal chemists for ligand optimisation endeavours.

Identifiers

PMID41535595
PMCPMC12867982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.